Monkey corticotropin-releasing factor1 receptor: Complementary DNA cloning and pharmacological characterization

Life Sciences

Volumn 74, Issue 15, 2004, Pages 1911-1924

  Oshida, Yuichi ^a   Ikeda, Yoko ^a   Chaki, Shigeyuki ^a   Okuyama, Shigeru ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

cDNA cloning; Corticotropin releasing factor; Functional expression; Monkey

Indexed keywords

4 [4 (3 FLUOROPHENYL) 1,2,3,6 TETRAHYDRO 1 PYRIDINYL] 2 [N ETHYL N (4 ISOPROPYL 2 METHYLTHIOPHENYL)AMINO] 6 METHYLPYRIMIDINE; ADENOSINE TRIPHOSPHATE; AMINO ACID; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; COMPLEMENTARY DNA; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CRF RECEPTOR TYPE 1; CYCLIC AMP; DRUG DERIVATIVE; G PROTEIN COUPLED RECEPTOR; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE TRIPHOSPHATE; IODINE 125; PRIMER DNA; RADIOACTIVE IODINE; RECEPTOR SUBTYPE; SAUVAGINE; SC 241; UNCLASSIFIED DRUG; UROTENSIN I;

AGAR GEL ELECTROPHORESIS; AMINO ACID SEQUENCE; AMYGDALOID NUCLEUS; ANIMAL; ANIMAL CELL; ARTICLE; BRAIN CORTEX; CELL STRAIN COS1; CERCOPITHECUS; CEREBELLUM; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA ISOLATION; DNA LIBRARY; DNA SEQUENCE; DRUG EFFECT; GENETIC CODE; GENETIC TRANSFECTION; GENETICS; HIPPOCAMPUS; HYPOPHYSIS; IC 50; MACACA; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN EXPRESSION; RHESUS MONKEY; SEQUENCE HOMOLOGY;

MACACA; MACACA MULATTA; OVIS;

EID: 0842324492     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.08.035     Document Type: Article

References (35)

1. Bakshi V.P., Smith-Roe S., Newman S.M., Grigriadis D.E., Kalin N.H. Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala. Journal of Neuroscience. 22:2002;2926-2935.
2. Chaki S., Okuyama S., Nakazato A., Kumagai T., Okubo T., Ikeda Y., Oshida Y., Hamajima Y., Tomisawa K. In vitro pharmacological profile of nonpeptide CRF1 receptor antagonists, CRA1000 and CRA1001. European Journal of Pharmacology. 371:1999;205-211.
3. Chalmers D.T., Lovenberg T.W., De Souza E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. Journal of Neuroscience. 15:1995;6340-6350.
4. Chang C.P., O'Connell S., Rosenfeld M.G. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron. 11:1993;1187-1195.
5. Chen R., Lewis K.A., Perrin M.H., Vale W.W. Expression cloning of a human corticotropin-releasing factor receptor. Proceedings of the National Academy of Sciences of the United States of America. 90:1993;8967-8971.
6. Dautzenberg F.M., Dietrich K., Palchaudhuri M.R., Spiess J. Identification of two corticotropin-releasing factor receptors from Xenopus laevis with high ligand selectivity: unusual pharmacology of the type 1 receptor. Journal of Neurochemistry. 69:1997;1640-1649.
7. Dautzenberg F.M., Wille S., Lohmann R., Spiess J. Mapping of the ligand-selective domain of Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site. Proceedings of the National Academy of Sciences of the United States of America. 95:1998;4941-4946.
8. Dautzenberg F.M., Kilpatrick G.J., Wille S., Hauger R.L. The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains; generation of chimeric receptors with novel ligand-selective profile. Journal of Neurochemistry. 73:1999;821-829.
9. Dautzenberg F.M., Py-Lang G., Higelin J., Ficher C., Wright M.B., Huber G. Different binding models of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences. Journal of Pharmacology and Experimental Therapeutics. 296:2001;113-120.
10. De Souza E.B. Corticotropin-releasing factor receptors in the rat central nervous system: characterization and regional distribution. Journal of Neuroscience. 7:1987;88-100.
11. Donaldson C.J., Sutton S.W., Perrin M.H., Corrigan A.Z., Lewis K.A., Rivier J.E., Vaughan J.M., Vale W.W. Cloning and characterization of human urocortin. Endocrinology. 137:1996;2167-2170.
12. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz H., Northrop J.P., Ringold G.M., Danielsen M. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proceedings of the National Academy of Sciences of the United States of America. 84:1987;7413-7417.
13. Grigoriadis D.E., Dent G.W., Turner J.G., Uno H., Shelton S.E., De Souza E.B., Kalin N.H. Corticotropin-releasing factor (CRF) receptors in infant rhesus monkey brain and pituitary gland: biochemical characterization and autoradiographic localization. Developmental Neuroscience. 17:1995;357-367.
14. Hauger R.L., Grigoriadis D.E., Dallman M.F., Plotsky P.M., Vale W.W., Dautzenberg F.M. International union of pharmacology. XXXVI. Current status of the nomenclature or receptors for corticotropin-releasing factor and their ligands. Pharmacological Reviews. 55:2003;21-26.
15. Hofmann B.A., Sydow S., Jahn O., van Werven L., Liepold T., Eckart K., Spiess J. Functional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1. Protein Science. 10:2001;2050-2062.
16. Kostich W.A., Chen A., Sperle K., Largent B.L. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: The CRF2γ receptor. Molecular Endocrinology. 12:1998;1077-1085.
17. Liaw C.W., Lovenberg T.W., Barry G., Oltersdorf T., Grigoriadis D.E., De Souza E.B. Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology. 137:1996;72-77.
18. Liaw C.W., Grigoriadis D.E., Lovenberg T.W., De Souza E.B., Maki R.A. Localization of ligand-binding domains of human corticotropin-releasing factor receptor: a chimeic receptor approach. Molecular Endocrinology. 11:1997;980-985.
19. Liaw C.W., Grigoriadis D.E., Lorang M.T., De Souza E.B., Maki R.A. Localization of agonist- and antagonist-binding domains of human corticotropin-releasing factor receptors. Molecular Endocrinology. 11:1997;2048-2053.
20. Lovenberg T.W., Liaw C.W., Grigoriadis D.E., Clevenger W., Chalmers D.T., De Souza E.B., Oltersdorf T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proceedings of the National Academy of Sciences of the United States of America. 92:1995;836-840.
21. Myers D.A., Trinh J.V., Myers T.R. Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant. Molecular and Cellular Endocrinology. 144:1998;21-35.
22. Perrin M.H., Donaldson C.J., Chen R., Lewis K.A., Vale W.W. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology. 133:1993;3058-3061.
23. Perrin M.H., Sutton S., Bain D.L., Berggren W.T., Vale W.W. The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin. Endocrinology. 139:1998;566-570.
24. Perrin M.H., Sutton S.W., Cervini L.A., Rivier J.E., Vale W.W. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors. Journal of Pharmacology and Experimental Therapeutics. 288:1999;729-734.
25. Qi L.J., Leung A.T., Xiong Y., Marx K.A., Abou-Samra A.B. Extracellular cysteines of the corticotropin-releasing factor receptor are critical for ligand interaction. Biochemistry. 36:1997;12442-12448.
26. Sanchez M.M., Young L.J., Plotsky P.M., Insel T.R. Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. Journal of Comparative Neurology. 408:1999;365-377.
27. Schulz D.W., Mansbach R.S., Sprouse J., Braselton J.P., Collins J., Corman M., Dunaiskis A., Faraci S., Schmidt A.W., Seeger T., Seymour P., Tingley F.D., Winston E.N., Chen Y.L., Heym J. CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proceedings of the National Academy of Sciences of the United States of America. 93:1996;10477-10482.
28. Sydow S., Flaccus A., Fischer A., Spiess J. The role of the fourth extracellular domain of the rat corticotropin-releasing factor receptor type 1 in ligand binding. European Journal of Biochemistry. 259:1999;55-62.
29. Takahashi L.K., Ho S.P., Livanov V., Graciani N., Arneric S.P. Antagonism of CRF2 receptor produces anxiolytic behavior in animal models of anxiety. Brain Research. 902:2001;135-142.
30. Takebe Y., Seiki M., Fujisawa J., Hoy P., Yokota K., Arai K., Yoshida M., Arai N. SRalpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Molecular and Cellular Biology. 8:1988;466-472.
31. Turnbull A.V., Rivier C. Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides. Proceedings of the Society for Experimental Biology and Medicine. 215:1997;1-10.
32. Valdenaire O., Giller T., Breu V., Gottowik J., Kilpatrick G. A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor. Biochimica et Biophysica Acta. 1352:1997;129-132.
33. Vale W., Spiess J., River C., River J. Characterization of 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 213:1981;1394-1397.
34. Vita N., Laurent P., Lefort S., Chalon P., Lelias J.M., Kaghad M., Le Fur G., Caput D., Ferrara P. Primary structure and functional expression of mouse pituitary and human brain corticotropin releasing factor receptors. FEBS Letters. 335:1993;1-5.
35. Wille S., Sydow S., Palchaudhuri M.R., Spiess J., Dautzenberg F.M. Identification of amino acids in the N-terminal domain of corticotropin- releasing factor receptor 1 that are important determinants of high-affinity ligand binding. Journal of Neurochemistry. 72:1999;388-395.